Latest news
OrbiMed discloses sub-10% Yarrow Bioscience, Inc. (Ticker: VYNE) stake and large warrants - Stock TitanStock Titan · Thu, 06 Aug 2026 02:18:28 GMTOrbiMed Advisors Discloses Investment at Yarrow Bioscience with 9.97% Stake - TradingViewTradingView · Thu, 06 Aug 2026 01:16:00 GMTBiogen Inc. completed the acquisition of RayThera, Inc. from Foresite Capital Management, LLC, OrbiMed Advisors LLC, TTM Capital and others. - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 22:00:00 GMTStempoint Capital LP Cuts Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTOrbiMed discloses pre-funded warrants in Yarrow Bioscience, Inc. (VYNE) - Stock TitanStock Titan · Thu, 30 Jul 2026 01:44:23 GMTYarrow Bioscience, Inc. (VYNE) director reports large OrbiMed warrants - Stock TitanStock Titan · Thu, 30 Jul 2026 01:44:23 GMTOrbiMed Advisors Discloses Investment in Scribe Therapeutics with 7.2% Stake - TradingViewTradingView · Wed, 29 Jul 2026 22:46:00 GMTArrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKeyTradingKey · Mon, 27 Jul 2026 19:19:43 GMT